Cardiac Implant Market Expects Rebound

According to a new independent study, the market for cardiac implants should see a 8.8% annual increase to reach $16.4 billion in 2012. Released by The Freedonia Group Inc. (Cleveland), the Cardiac Implants report suggests that performance problems with ICDs could be improved with the development of next generation devices and better materials.

September 16, 2008

1 Min Read
Cardiac Implant Market Expects Rebound

The fact that current drugs don't always do the trick could also help implants that treat and manage coronary and peripheral artery diseases, cardiac arrhythmia, congestive heart failure, and valve defects.Pacing devices will stay at the top among cardiac implants and are expected to increase 7.8% each year to hit $8.7 billion in 2012. Improved drug-eluting stent design, along with a lower risk of complications could push cardiac stents and stent-related implants to $6.4 billion in 2012 (a more than 10% annual increase).The study also covered tissue heart valves, which are expected take some demand from mechanical heart valves. Improvements in diagnostics will also increase the use of implantable heart monitors for patients with congestive heart failure.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like